Pharma Manufacturing Covid-19 Challenge

About Book

ISBN
Presentation PDF, 62 Pages
Edition 1st Edition 2020
Weight PDF
Author Research Team
Price USD 50
Availability In Stock

In December 2019, China began noticing a disturbing trend of pneumonia like cases that were fast multiplying in the city of Wuhan, the sprawling capital of central China’s Hubei province. They are commonly thought to have originated from a wet market in city centre called Huanan Seafood Wholesale Market. This outbreak turned into a juggernaut rampaging through all corners of the world, turning into a pandemic never seen before in living memory. Pharmaceutical manufacturing is a critical component of our fightback to ensure regular uninterrupted supply of medicines and vaccines for the patients. In the numerous lockdowns implemented in various countries this brought fresh challenges for continuous operations of pharmaceutical facilities. This publication has been brought out to provide collated information of practical and immediate use of pharma companies to keep their operations running.

Note: On successful completion of order and payment, the PDF file will be sent by email. 

Pharma Manufacturing Covid-19 Challenge

CONTENTS

1.     Understanding the Disease

        Introduction

  • What is it?
  • Disease Characteristics
  • Symptoms of COVID-19
  • Complications
  • Transmission

2.    The Covid 19 Challenge – 2020 and Beyond

       The New Normal

  • Collaboration is the New Game
  • Opportunities out of Chaos
  • Business Continuity Management
  • People Management
    •         Infection Proliferation
    •         IT Hardware – Software Challenges
    •         Inadequate Manpower Availability
    •         Contract Employees Challenges
  • Work From Home Cybersecurity Issues
  • Insurance
  • Finance and Cash Flow
  • Commercial and Legal Challenges
  • New Workplace Guidelines

3.    Pharma Supply Chain

  • Components of Supply Chain
  • Supply Chain Continuity Planning
  • Geopolitics in Supply Chain Management
    • Diversification of Pharmaceutical Manufacturing
    • Cost Benefit Analysis
    • Political Compulsions
    • Opportunities for India

4.    Pharma Manufacturing in a Pandemic

  • Cleaning and Disinfection
    • Assessment
    • Planning
    • Selection of Proper Disinfectants
    • Disinfectant Mixing
    • Personnel Requirements
    • Implementation

 

    • ULV Fogging
    • Ozone Disinfection
    • Ultraviolet Light Disinfection
    • Cleaning and Disinfecting Vehicles
  • Material and Personnel Entry
    • Employee Transit
    • Plant Entry
    • Change Rooms / Washrooms
    • Engineering and Maintenance
    • Shift Handover
    • Material Movement
    • General Workplace Covid-19 Procedures
  • Regulatory Compliance
    • Manufacturing
    • Quality Control
    • Quality Assurance
    • Documentation

5.    References


New User?

Bookseller?